Content Uniformity (CU) testing for the 21st Century: CDER Perspective Richard (Rik) Lostritto, Ph.D. Acting Deputy Office Director for Science and Policy and Biopharmaceutics Lead Office of New Drug Quality Assessment ( - 21st Century Medicine - Document - PDFSEARCH.IO

First Page	Meta Content
	Content Uniformity (CU) testing for the 21st Century: CDER Perspective Richard (Rik) Lostritto, Ph.D. Acting Deputy Office Director for Science and Policy and Biopharmaceutics Lead Office of New Drug Quality Assessment ( Add to Reading List Open Document File Size: 311,04 KB Share Result on Facebook Company Process Analytical Technologies / Real Time / / IndustryTerm wet chemical analyses / device combination products / / Organization Acting Deputy Office / office of Pharmaceutical Science / Center for Drug Evaluation and Research / Policy and Biopharmaceutics Lead office of New Drug Quality Assessment / / Person Perspective Richard (Rik) Lostritto / / Position Director for Science / arbiter / / Technology AV / / SocialTag Pharmaceutical industry USP Tablet Sample size determination Mean Medicine Dosage forms Pharmaceutical sciences Pharmacology

Content Uniformity (CU) testing for the 21st Century: CDER Perspective Richard (Rik) Lostritto, Ph.D. Acting Deputy Office Director for Science and Policy and Biopharmaceutics Lead Office of New Drug Quality Assessment (Add to Reading List